Trial Profile
Efficacy and safety of intravitreal injections of aflibercept (IVA) in Japanese polypoidal choroidal vasculopathy (PCV) patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- Acronyms APOLLO
- 23 Oct 2017 New trial record